Neogen Chemicals Ltd - 542665 - Disclosure Under Regulation 23(9) Of The SEBI (Listing Obligations And Disclosures Requirements) Regulations, 2015.
In terms of Regulation 23(9) of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, we enclose herewith the disclosure of Related Party Transactions on a consolidated basis in the format specified in the Accounting Standards for the half year ended March 31, 2020. Neogen Chemicals Ltd - 542665 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 (6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that a conference call with various Analysts and Investors have been organized on Tuesday, June 16, 2020. The discussion will be under the purview of Neogen Chemicals' Q4 and F.Y. 2019-20 Earnings Presentation which has already been uploaded on the websites of BSE Limited and National Stock Exchange of India Limited and also on the Company website www.neogenchem.com. Neogen Chemicals Ltd - 542665 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Haridas Thakarshi Kanani Neogen Chemicals Ltd - 542665 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Beena Haridas Kanani Neogen Chemicals Ltd - 542665 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Beena Haridas Kanani Neogen Chemicals Ltd - 542665 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find enclosed herewith the Press Release dated June 3, 2020 titled 'Neogen Chemicals adds another marquee investor to its list of shareholders as promoters divest 11.26 lakh shares'. We request you to kindly take the above on your records and disseminate the same on your website. Neogen Chemicals Ltd - 542665 - Board recommends Final Dividend
Neogen Chemicals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 23, 2020, inter alia, has recommended a final dividend of Rs. 2/- per Equity Share for the Financial Year 2019-20, subject toapproval of Shareholders at the ensuing Annual General Meeting of the Company. Neogen Chemicals Ltd - 542665 - Announcement under Regulation 30 (LODR)-Investor Presentation
Please find attached Investors Presentation for the 4th quarter and Financial Year ended March 31, 2020 Neogen Chemicals Ltd - 542665 - Outcome Of Board Meeting Held On May 23, 2020.
The meeting of the Board of Directors of the Company which commenced at 3.00 P.M and concluded at 11.35 P.M. today i.e. May 23, 2020, the following decisions were taken:1)Approval of Audited Standalone & Consolidated Financial Results of the Company along with the Audit Reports for the Quarter & FY ended March 31, 2020,which has been duly reviewed and recommended by the Audit Committee;Further as required in terms of Regulation 33(3) (d) of the Listing Regulations, we would like to confirm that the Statutory Auditors of the Company M/s JMT & Associates, Chartered Accountants (FRN: 104167W) have issued the Auditors Report on Audited (Standalone and Consolidated) Financial Results of the Company for the Quarter and Financial Year ended March 31, 2020 with un-modified opinion.2) Recommendation of a final dividend of Rs. 2/- per Equity Share for the Financial Year 2019-20, subject to approval of Shareholders at the ensuing Annual General Meeting of the Company. Neogen Chemicals Ltd - 542665 - Outcome Of Board Meeting Held On May 23, 2020.
The meeting of the Board of Directors of the Company which commenced at 3.00 P.M and concluded at 11.35 P.M. today i.e. May 23, 2020, the following decisions were taken: 1.Approval of Audited Standalone and Consolidated Financial Results of the Company along with the Audit Reports for the Quarter and F.Y. ended March 31, 2020, which has been duly reviewed and recommended by the Audit Committee;Further as required in terms of Regulation 33(3) (d) of the Listing Regulations, we would like to confirm that the Statutory Auditors of the Company M/s JMT & Associates, Chartered Accountants (FRN: 104167W) have issued the Auditors Report on Audited (Standalone and Consolidated) Financial Results of the Company for the Quarter and F.Y. ended March 31, 2020 with un-modified opinion.3.Recommendation of a final dividend of Rs. 2/- per Equity Share for the FY 2019-20, subject to approval of Shareholders at the ensuing Annual General Meeting of the Company.